Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1015-1016, Issue , 2016, Pages 50-61

  Chu, Hang ^a   Zhang, Aihua ^a   Han, Ying ^a   Lu, Shengwen ^a   Kong, Ling ^a   Han, Jinwei ^a   Liu, Zhidong ^a   Sun, Hui ^a   Wang, Xijun ^a  

^a National TCM Key Lab of Serum Pharmacochemistry   (China)

Author keywords

Alzheimer's disease; Kai Xin San; Metabolomics; SYNAPT G2 Si HDMS; Traditional chinese medicine

Indexed keywords

ALUMINUM CHLORIDE; BIOMARKERS; BIOMOLECULES; BRAIN; DIAGNOSIS; DRUG PRODUCTS; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINE; METABOLISM; METABOLITES; PATTERN RECOGNITION; SPECTROMETRY;

ALZHEIMER'S DISEASE; KAI-XIN-SAN; METABOLOMICS; SYNAPT G2-SI HDMS; TRADITIONAL CHINESE MEDICINE;

NEURODEGENERATIVE DISEASES;

ALUMINUM CHLORIDE; CHINESE DRUG; GALACTOSE; HERBACEOUS AGENT; KAI XIN SAN; LEUCINE ENKEPHALIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEMORY; METABOLOMICS; MORRIS WATER MAZE TEST; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PROCEDURES; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; CA3 REGION, HIPPOCAMPAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84958156043     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.02.007     Document Type: Article

References (41)

1. Association A. Alzheimer's disease facts and figures. Alzheimers Dement. 2014, 10:e47-e92.
2. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
3. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta 2014, 1842:1219-1231.
4. Bonda D.J., Wang X., Perry G., Nunomura A., Tabaton M., Zhu X., Smith M.A. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010, 59:290-294.
5. González-Domínguez R., García-Barrera T., Gómez-Ariza J.L. Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease. Electrophoresis 2015, 36:577-587.
6. Povova J., Ambroz P., Bar M., Pavukova V., Sery O., Tomaskova H., Janout V. Epidemiological of and risk factors for Alzheimer's disease: a review. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 2012, 156:108-114.
7. Nordberg A. Towards early diagnosis in Alzheimer disease. Nat. Rev. Neurol. 2015, 11:69-70.
8. Zhang A., Sun H., Qiu S., Wang X. Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula. Evid. Based Complement. Alternat. Med. 2013, 10:568-579.
9. Nishiyama N., Zhou Y., Saito H. Beneficial effects of DX-9386 a traditional Chinese prescription, on memory disorder produced by lesioning the amygdala in mice. Biol. Pharm. Bull. 1994, 17:1679-1681.
10. Wang W., Liao Q.P., Quan L.H., Liu C.Y., Xin Q.C., Liu M., Liao Y.H. The effect of Acorus gramineus on the bioavailabilities and brain concentrations of ginsenosides Rg1, Re and Rb1after oral administration of Kai-Xin-San preparations in rats. J. Ethnopharmacol. 2010, 131:313-320.
11. Hu Y., Zhou X.J., Liu P., Dong X.Z., Mu L.H., Chen Y.B., Liu M.Y., Yu B.Y. Antidepressant and neuroprotective effect of the chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-Induced injury in vitro and in vivo. Neuropsychobiology 2014, 69:129-139.
12. Zhou X.J., Liu M., Yan J.J., Cao Y., Liu P. Antidepressant-like effect of the extracted of Kai Xin San a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in rat. J. Ethnopharmacol. 2012, 139:422-428.
13. Zhang A., Liu Q., Zhao H., Zhou X., Sun H., Nan Y., Zou S., Ma C.W., Wang X. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention. Sci. Rep. 2016, 6:19333.
14. Wang X., Zhang A., Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012, 16(7-8):414-421.
15. Nan Y, Zhou X, Liu Q, Zhang A, Guan Y, Lin S, Kong L, Han Y, Wang X. Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome. J Chromatogr B Analyt Technol Biomed Life Sci. 2015. pii: S1570-0232(15) 30328-7.
16. Sun H., Liu C., Zhang A.H., Han Y., Yan G.L., Wang P., Wang X.J. Rapid discovery and global characterization of multiple constituents from Kai-Xin-San using an integrated MSE data acquisition mode strategy based on ultra-performance liquid chromatography coupled to electrospray ionization/quadrupole-time-of-flight mass spectrometry. Anal. Methods 2014, 7:279-286.
17. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
18. Mapstone M., Cheema A.K., Fiandaca M.S., Zhong X., Mhyre T.R., MacArthur L.H., Hall W.J., Fisher S.G., Peterson D.R., Haley J.M., Nazar M.D., Rich S.A., Berlau D.J., Peltz C.B., Tan M.T., Kawas C.H., Federoff H.J. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 2014, 20:4.
19. Gika H.G., Theodoridis G.A., Wingate J.E., Wilson I.D. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome Res. 2007, 6:3291-3303.
20. Xia J.G., Wishart D.S. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 2010, 26:2342-2344. (3).
21. Kanehisa M., Goto S., Kawashima S., Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res. 2002, 30:42-46.
22. Sun Z.Z., Chen Z.B., Jiang H., Li L.L., Li E.G., Xu Y. Alteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and d-galactose. AGE 2009, 31:277-284.
23. Migliore L., Fontana I., Colognato R., Coppede F., Siciliano G., Murri L. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol. Aging 2005, 26:587-595.
24. Storga D., Vrecko K., Birkmayer J.G.D., Reibnegger G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci. Lett. 1996, 203:29-32.
25. Mielke M.M., Lyketsos C.G. Lipids and the pathogenesis of Alzheimer's disease: is there a link?. Int. Rev. Psychiatry 2006, 18:173-186.
26. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J. Neural Transm. 2000, 107:1027-1063.
27. Mielke M.M., Lyketsos C.G. Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?. Neuromol. Med. 2010, 12:331-340.
28. Iuliano L., Pacelli A., Ciacciarelli M., Zerbinati C., Fagioli S., Piras F., Orfei M.D., Bossù P., Pazzelli F., Serviddio G., Caltagirone C., Spalletta G. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Dis. 2013, 36:545-553.
29. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., Folsom A.R. Plasma n-fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 2007, 85:1103-1111.
30. Inouye M., Mio T., Sumino K. Formation of 9-hydroxy linoleic acid as a product of phospholipid peroxidation in diabetic erythrocyte membranes. Biochim. Biophys. Acta 1999, 1438:204-212.
31. Nemati A., Mahdavi R., Faizi-Khankandi I., Amani M., Hazrati S., Baghi A.N., Mazani M., Amani F. Effects of omega-fatty acids supplementation on oxidative stress and MMP2/9 in patients with gastric cancer during chemotherapy. J. Anim. Vet. Adv. 2012, 11:1858.
32. Wang Z.Y., Figueiredo-Pereira M.E. Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. Mol. Cell. Neurosci. 2005, 29:222-231.
33. Lee S.Y., Ahn J.H., Ko K.W., Kim J., Jeong S.W., Kim I.K., Kim J., Kim H.S. Prostaglandin A2 activates intrinsic apoptotic pathway by direct interaction with mitochondria in HL-60 cells. Prostaglandins Other Lipid Mediat. 2010, 91:30-37.
34. Zhang W.Q., Hua Y.L., Zhang M., Ji P., Li J.X., Zhang L., Li P.L., Wei Y.M. Metabonomic analysis of the anti-inflammatory effects of volatile oils of Angelica sinensis on rat model of acute inflammation. Biomed. Chromatogr. 2015, 29:902-910.
35. Mizugishi K., Yamashita T.A., Miller G.F., Spiegel S., Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Bio. 2005, 25:11113-11121.
36. Li G., Hu R. Association between serum sulfatide and carotid intima media thickness in patients with familial hypercholesterolemia. Glycoconj. J. 2014, 31:587-592.
37. Mandal P.K., Mcclure R.J., Pettegrew J.W. Interactions of Abeta (1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studies. Neurochem. Res. 2004, 29:2273-2279.
38. Walter A., Korth U., Hilgert M., Hartmann J., Weichel O., Hilgert M., Fassbender K., Schmitt A., Klein J. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol. Aging 2004, 25:1299-1303.
39. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., Rice K.C., Basile A.S. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J. Pharmacol. Exp. Ther. 2001, 299:332-342.
40. Murillo-Rodriguez E., Giordano M., Cabeza R., Henriksen S.J., Diaz M.M., Navarro L., Prospero-Garcia O. Oleamide modulates memory in rats. Neurosci. Lett. 2001, 313:61-64.
41. Heo H.J., Park Y.J., Suh Y.M., Choi S.J., Kim M.J., Cho H.Y., Chan Y.J., Hong B., Kim H.K., Kim E., Kim C.J., Kim B.G., Shin D.H. Effects of oleamide on choline acetyltransferase and cognitive activities. Biosci. Biotech. Biochem. 2003, 67:1284-1291.